CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
Hyun Min Kim, Jung Soo Lim, Byung-Wan Lee, Eun-Seok Kang, Hyun Chul Lee, Bong-Soo Cha
Endocrinol Metab. 2015;30(1):84-91.   Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.84

Excel Download

Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus
Endocrinology and Metabolism. 2015;30(1):84   Crossref logo
Link1 Link2 Link3

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin
Diabetes, Obesity and Metabolism. 2007;9(5):733-745   Crossref logo
Link1 Link2

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus
Diabetes mellitus. 2013;16(4):95-100   Crossref logo
Link1 Link2 Link3

Evaluation of fixed dose combination of glimepiride and metformin in patients with type 2 diabetes. Results of Russian observational study
Diabetes mellitus. 2015;18(2):84-88   Crossref logo
Link1 Link2

Glimepiride Strongly Enhances the Glucose-Lowering Effect in Triple Oral Antidiabetes Therapy with Sitagliptin and Metformin for Japanese Patients with Type 2 Diabetes Mellitus
Diabetes Technology & Therapeutics. 2013;15(4):335-341   Crossref logo
Link1 Link2

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial)
Diabetes, Obesity and Metabolism. 2017;19(8):1188-1192   Crossref logo
Link1 Link2

PO196 LOW-DOSE GLIMEPIRIDE WITH SITAGLIPTIN IMPROVES GLYCEMIC CONTROL WITHOUT DOSE-DEPENDENCY IN PATIENTS WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON HIGH-DOSE GLIMEPIRIDE
Diabetes Research and Clinical Practice. 2014;106:S148   Crossref logo
Link1 Link2

Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination
Journal of Diabetes Investigation. 2013;5(3):320-326   Crossref logo
Link1 Link2 Link3

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
Diabetes mellitus. 2010;13(1):50-54   Crossref logo
Link1 Link2

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia
Journal of Diabetes Investigation. 2018;10(2):383-391   Crossref logo
Link1 Link2